Cargando…
The evolution of drug resistance in clinical isolates of Candida albicans
Candida albicans is both a member of the healthy human microbiome and a major pathogen in immunocompromised individuals. Infections are typically treated with azole inhibitors of ergosterol biosynthesis often leading to drug resistance. Studies in clinical isolates have implicated multiple mechanism...
Autores principales: | Ford, Christopher B, Funt, Jason M, Abbey, Darren, Issi, Luca, Guiducci, Candace, Martinez, Diego A, Delorey, Toni, Li, Bi yu, White, Theodore C, Cuomo, Christina, Rao, Reeta P, Berman, Judith, Thompson, Dawn A, Regev, Aviv |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4383195/ https://www.ncbi.nlm.nih.gov/pubmed/25646566 http://dx.doi.org/10.7554/eLife.00662 |
Ejemplares similares
-
Coordinated host-pathogen transcriptional dynamics revealed using sorted subpopulations and single macrophages infected with Candida albicans
por: Muñoz, José F., et al.
Publicado: (2019) -
Y(MAP): a pipeline for visualization of copy number variation and loss of heterozygosity in eukaryotic pathogens
por: Abbey, Darren A, et al.
Publicado: (2014) -
High-Resolution SNP/CGH Microarrays Reveal the Accumulation of Loss of Heterozygosity in Commonly Used Candida albicans Strains
por: Abbey, Darren, et al.
Publicado: (2011) -
Genome Sequence for Candida albicans Clinical Oral Isolate 529L
por: Cuomo, Christina A., et al.
Publicado: (2019) -
Correction: Evolutionary principles of modular gene regulation in yeasts
por: Thompson, Dawn A, et al.
Publicado: (2013)